ESCITALOPRAM IN TREATMENT OF DISABILITY IN MAJOR DEPRESSIVE PATIENTS

被引：0
|
作者：
Zivkovic, N. [1 ]
Pavicevic, D. [1 ]
Djokic, G. [1 ]
机构：
[1] Inst Neuropsychiat Laza Lazarev, Belgrade, Serbia
来源：
EUROPEAN PSYCHIATRY | 2010年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Escitalopram prevents relapse in older patients with major depressive disorder
    Gorwood, Philip
    Weiller, Emmanuelle
    Lemming, Ole
    Katona, Cornelius
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2007, 15 (07): : 581 - 593
  • [22] Combining escitalopram with gaboxadol provides no additional benefit in the treatment of patients with severe major depressive disorder
    Kasper, S.
    Ebert, B.
    Larsen, K.
    Tonnoir, B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S408 - S408
  • [23] Combining escitalopram with gaboxadol provides no additional benefit in the treatment of patients with severe major depressive disorder
    Kasper, Siegfried
    Ebert, Bjarke
    Larsen, Klaus
    Tonnoir, Brigitte
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 (06): : 715 - 725
  • [24] Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder
    Clayton, Anita
    Kornstein, Susan
    Prakash, Apurva
    Mallinckrodt, Craig
    Wohlreich, Madelaine
    JOURNAL OF SEXUAL MEDICINE, 2007, 4 (04): : 917 - 929
  • [25] Cognitive and psychomotor effects of three months of escitalopram treatment in elderly patients with major depressive disorder
    Beheydt, Lieve Lia
    Schrijvers, Didier
    Docx, Lise
    Bouckaert, Filip
    Hulstijn, Wouter
    Sabbe, Bernard
    JOURNAL OF AFFECTIVE DISORDERS, 2015, 188 : 47 - 52
  • [26] A genome-wide association study of escitalopram treatment outcomes in patients with major depressive disorder
    Ren, Siyu
    Peng, He
    Zhang, Jinniu
    Yang, Jian
    He, Yi
    Sun, Zuoli
    Wang, Gang
    GENE, 2024, 926
  • [27] Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram in patients with major depressive disorder
    Schmitt, Laurent
    Tonnoir, Brigitte
    Arbus, Christophe
    NEUROPSYCHOBIOLOGY, 2006, 54 (04) : 201 - 207
  • [28] Escitalopram is a new and highly efficacious SSRI in the treatment of major depressive disorder
    Montgomery, SA
    Huusom, AKT
    Bothmer, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S254 - S255
  • [29] Superiority of Escitalopram over Paroxetine in the treatment of Major Depressive Disorder (MDD)
    Kasper, S.
    Baldwin, D.
    Boulenger, J. P.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2008, 12 (04) : 337 - 337
  • [30] Escitalopram vs. venlafaxine XR treatment of major depressive disorder
    Montgomery, S
    Bielski, RJ
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S169 - S169
12345